SCM

Sio Capital Management Portfolio holdings

AUM $249M
This Quarter Return
-1.42%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$369M
AUM Growth
+$369M
Cap. Flow
-$92.5M
Cap. Flow %
-25.08%
Top 10 Hldgs %
41.09%
Holding
105
New
15
Increased
19
Reduced
22
Closed
29

Top Buys

1
AVAH icon
Aveanna Healthcare
AVAH
$14.9M
2
AMGN icon
Amgen
AMGN
$8.53M
3
ITGR icon
Integer Holdings
ITGR
$6.3M
4
HQY icon
HealthEquity
HQY
$5.23M
5
CHAQ.U
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$4.37M

Top Sells

1
CAH icon
Cardinal Health
CAH
$13.8M
2
MRK icon
Merck
MRK
$9.64M
3
AMN icon
AMN Healthcare
AMN
$9.5M
4
ICLR icon
Icon
ICLR
$9.33M
5
GSK icon
GSK
GSK
$9.19M

Sector Composition

1 Healthcare 86.66%
2 Consumer Staples 2.21%
3 Technology 0.96%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$102B
$4.82M 1.2%
23,900
+2,833
+13% +$571K
KURA icon
27
Kura Oncology
KURA
$732M
$4.63M 1.15%
222,263
+8,792
+4% +$183K
CCRN icon
28
Cross Country Healthcare
CCRN
$420M
$4.62M 1.15%
279,850
-153,394
-35% -$2.53M
RDUS
29
DELISTED
Radius Health, Inc.
RDUS
$4.4M 1.09%
240,957
+10,000
+4% +$182K
CHAQ.U
30
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$4.37M 1.09%
+400,000
New +$4.37M
SYRS
31
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4.36M 1.08%
+80,000
New +$4.36M
NARI
32
DELISTED
Inari Medical, Inc. Common Stock
NARI
$4.32M 1.07%
+46,332
New +$4.32M
EPIX icon
33
ESSA Pharma
EPIX
$11.2M
$4.23M 1.05%
148,127
-164,584
-53% -$4.7M
NBSE
34
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$4.16M 1.03%
43,435
+23,750
+121% +$2.28M
ARDX icon
35
Ardelyx
ARDX
$1.57B
$3.99M 0.99%
525,996
-194,625
-27% -$1.48M
AUTL
36
Autolus Therapeutics
AUTL
$383M
$3.93M 0.98%
+591,870
New +$3.93M
VKTX icon
37
Viking Therapeutics
VKTX
$3.02B
$3.71M 0.92%
619,780
+50,000
+9% +$299K
MBRX icon
38
Moleculin Biotech
MBRX
$11.3M
$3.69M 0.92%
66,990
+2,790
+4% +$154K
DTIL icon
39
Precision BioSciences
DTIL
$59.5M
$3.67M 0.91%
9,781
-1,198
-11% -$450K
RIGL icon
40
Rigel Pharmaceuticals
RIGL
$710M
$3.6M 0.9%
+82,972
New +$3.6M
ASGN icon
41
ASGN Inc
ASGN
$2.35B
$3.56M 0.88%
36,692
+2,115
+6% +$205K
EUCRU
42
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$3.06M 0.76%
300,000
– –
MGNX icon
43
MacroGenics
MGNX
$121M
$3.02M 0.75%
112,587
-17,413
-13% -$468K
SYRE icon
44
Spyre Therapeutics
SYRE
$1.02B
$2.8M 0.7%
16,106
– –
GYRE icon
45
Gyre Therapeutics
GYRE
$734M
$2.7M 0.67%
83,186
– –
PRQR icon
46
ProQR Therapeutics
PRQR
$256M
$2.56M 0.64%
380,045
-12,776
-3% -$86.1K
OBIO icon
47
Orchestra BioMed
OBIO
$147M
$2.55M 0.63%
250,000
– –
AMN icon
48
AMN Healthcare
AMN
$760M
$2.52M 0.63%
26,001
-97,897
-79% -$9.5M
CYCC icon
49
Cyclacel Pharmaceuticals
CYCC
$17.2M
$2.47M 0.61%
+116
New +$2.47M
CBAY
50
DELISTED
Cymabay Therapeutics
CBAY
$2.45M 0.61%
562,339
– –
1
2
3 4 5